Trial · NCT01091116
Results by group245
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 245
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| WOMAC VA 3.1 A Score (Total Pain) | Low Dose | 1 week post dose 1 | -60 | Standard Deviation 84 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Mid Dose | 1 week post dose 1 | -58 | Standard Deviation 82 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | High Dose | 1 week post dose 1 | -52 | Standard Deviation 92 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Single High Dose | 1 week post dose 1 | -67 | Standard Deviation 91 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Placebo | 1 week post dose 1 | -63 | Standard Deviation 103 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Low Dose | 2 weeks post dose 1 | -69 | Standard Deviation 89 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Mid Dose | 2 weeks post dose 1 | -65 | Standard Deviation 81 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | High Dose | 2 weeks post dose 1 | -71 | Standard Deviation 102 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Single High Dose | 2 weeks post dose 1 | -73 | Standard Deviation 96 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Placebo | 2 weeks post dose 1 | -75 | Standard Deviation 93 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Low Dose | 3 weeks post dose 1 | -103 | Standard Deviation 107 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Mid Dose | 3 weeks post dose 1 | -99 | Standard Deviation 86 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | High Dose | 3 weeks post dose 1 | -99 | Standard Deviation 104 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Single High Dose | 3 weeks post dose 1 | -103 | Standard Deviation 99 | mm |
| WOMAC VA 3.1 A Score (Total Pain) | Placebo | 3 weeks post dose 1 | -103 | Standard Deviation 112 | mm |
| WOMAC VA 3.1.B Score (Knee Stiffness) | Low Dose | Baseline | 105.7 | Standard Deviation 47.36 | mm |
| WOMAC VA 3.1.B Score (Knee Stiffness) | Mid Dose | Baseline | 101.8 | Standard Deviation 39.70 | mm |
| WOMAC VA 3.1.B Score (Knee Stiffness) | High Dose | Baseline | 109.4 | Standard Deviation 46.21 | mm |
| WOMAC VA 3.1.B Score (Knee Stiffness) | Single High Dose | Baseline | 107.3 | Standard Deviation 43.30 | mm |
| WOMAC VA 3.1.B Score (Knee Stiffness) | Placebo | Baseline | 108.7 | Standard Deviation 47.67 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01091116/results